Defining the involvement of p38alpha MAPK in the production of anti- and proinflammatory cytokines using an SB 203580-resistant form of the kinase.
about
Therapeutic targets in the ASK1-dependent stress signaling pathwaysThe p38alpha mitogen-activated protein kinase as a central nervous system drug discovery target.MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana.The effect of p38 mitogen-activated protein kinase activation on inflammatory liver damage following hemorrhagic shock in rats.An efficient proteomics method to identify the cellular targets of protein kinase inhibitors.A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock.Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model.Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanismsMAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock.p38α senses environmental stress to control innate immune responses via mechanistic target of rapamycinA potent and selective p38 inhibitor protects against bone damage in murine collagen-induced arthritis: a comparison with neutralization of mouse TNFalpha.Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1.Emodin Isolated from Polygoni cuspidati Radix Inhibits TNF-α and IL-6 Release by Blockading NF-κB and MAP Kinase Pathways in Mast Cells Stimulated with PMA Plus A23187."Go upstream, young man": lessons learned from the p38 saga.Antiinflammatory effects of traditional Korean medicine, JinPi-tang and its active ingredient, hesperidin in HaCaT cells.Anti-inflammatory activity of Schizonepeta tenuifolia through the inhibition of MAPK phosphorylation in mouse peritoneal macrophages.Elevated mitogen-activated protein kinase signalling and increased macrophage activation in cells infected with a glycopeptidolipid-deficient Mycobacterium avium.Inhibitory effects of chelidonic acid on IL-6 production by blocking NF-κB and caspase-1 in HMC-1 cells.Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-Ras.Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica Type III secretion system leads to attenuated nonclassical macrophage activation.Peripheral injection of SB203580 inhibits the inflammatory-dependent synthesis of proinflammatory cytokines in the hypothalamus.Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFαCyclodextrin curcumin formulation improves outcome in a preclinical pig model of marginal kidney transplantation.The E3 ubiquitin ligase Itch inhibits p38α signaling and skin inflammation through the ubiquitylation of Tab1.Induction of interleukin-10 expression through Fcalpha receptor in human monocytes and monocyte-derived dendritic cells: role of p38 MAPKinase.
P2860
Q26999030-EEBC18D6-FD08-455F-ABE4-BD43AAB80630Q33393902-A730AA96-51F6-4AAE-9650-6E8EF36EA187Q33750045-1DE84523-C1C6-4687-BF74-555AFB53A842Q34131109-31F74206-D445-4928-A44D-8AA5C65B5308Q34787933-61DE4462-A2DE-4C25-BFDD-0C76EACB4524Q35287077-5B4A82E3-E65F-454A-8B30-4973B12693F9Q35535693-A96C4F02-CAAD-46F4-B86C-8E621F534DE8Q36071692-E80C09D4-494A-4011-852C-D36C38E501DCQ36148425-BA25D5C2-E24D-40AB-ABFC-92D60E96D08AQ36227887-E2F5B557-D785-4EE2-B943-0870A517C317Q36586138-D4EB7ED8-294C-4E0E-BC04-F1E19A96A175Q36735853-85AF4A59-35F9-4F45-8DD1-B0B715FEA01AQ37064542-6F966076-0202-46B7-B371-6FB6511FDC5BQ37429748-7FE0E453-3C13-4CD6-8A96-DC717852186AQ37649076-F3E6561E-1280-469D-8989-FC40F687E144Q38469736-57DE3B01-C4DC-4FCF-B5A9-DFE7332A7DEEQ38497536-712755D2-2CD6-4A41-B937-058129E4D4FDQ38907765-33435ADF-3625-43A4-B8FB-0E164A15526DQ39592545-41F52D5E-6177-4D5C-B991-88DD7AC165C0Q40453381-A2100EAD-F6F2-42CE-ABA3-3F4B5C5D6153Q40735820-4A1C7113-6756-4CA3-9F55-D0ECDF8B3AC9Q40962111-D781553A-C55A-4142-B200-11432D1C1C31Q42608624-934E6D1A-02CB-4A03-A187-5ABF5B03F9CBQ50711738-2D1AA32D-64F6-47DD-9DCB-2E88F0D6B5A5Q53604232-FEAFBE3E-4CF3-40A2-9BCD-7B8E51F2551CQ54445810-C23E4363-F11A-45F4-A231-E4177EDFE8D0
P2860
Defining the involvement of p38alpha MAPK in the production of anti- and proinflammatory cytokines using an SB 203580-resistant form of the kinase.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Defining the involvement of p3 ...... -resistant form of the kinase.
@en
type
label
Defining the involvement of p3 ...... -resistant form of the kinase.
@en
prefLabel
Defining the involvement of p3 ...... -resistant form of the kinase.
@en
P2093
P2860
P356
P1476
Defining the involvement of p3 ...... -resistant form of the kinase.
@en
P2093
John W Schrader
Robert E Gerl
Xuecui Guo
P2860
P304
22237-22242
P356
10.1074/JBC.M300847200
P407
P577
2003-03-11T00:00:00Z